Efficacy and Safety of HB0034 in Patients with Generalized Pustular Psoriasis (GPP)

Clinical trial NCT06231381 · RECRUITING

Trial details

NCT number: NCT06231381
Sponsor: Shanghai Huaota Biopharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Generalized Pustular Psoriasis (GPP)

Start date: 2024-02-29
Primary completion: 2025-02-13
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.